1. Home
  2. IMMP vs VBF Comparison

IMMP vs VBF Comparison

Compare IMMP & VBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • VBF
  • Stock Information
  • Founded
  • IMMP 1987
  • VBF 1970
  • Country
  • IMMP Australia
  • VBF United States
  • Employees
  • IMMP N/A
  • VBF N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • VBF Trusts Except Educational Religious and Charitable
  • Sector
  • IMMP Health Care
  • VBF Finance
  • Exchange
  • IMMP Nasdaq
  • VBF Nasdaq
  • Market Cap
  • IMMP 211.1M
  • VBF 172.3M
  • IPO Year
  • IMMP N/A
  • VBF N/A
  • Fundamental
  • Price
  • IMMP $1.50
  • VBF $15.00
  • Analyst Decision
  • IMMP Buy
  • VBF
  • Analyst Count
  • IMMP 2
  • VBF 0
  • Target Price
  • IMMP $8.50
  • VBF N/A
  • AVG Volume (30 Days)
  • IMMP 84.6K
  • VBF 45.5K
  • Earning Date
  • IMMP 05-02-2025
  • VBF 01-01-0001
  • Dividend Yield
  • IMMP N/A
  • VBF 5.18%
  • EPS Growth
  • IMMP N/A
  • VBF N/A
  • EPS
  • IMMP N/A
  • VBF N/A
  • Revenue
  • IMMP $3,019,249.00
  • VBF N/A
  • Revenue This Year
  • IMMP N/A
  • VBF N/A
  • Revenue Next Year
  • IMMP $20.28
  • VBF N/A
  • P/E Ratio
  • IMMP N/A
  • VBF N/A
  • Revenue Growth
  • IMMP 24.11
  • VBF N/A
  • 52 Week Low
  • IMMP $1.32
  • VBF $13.68
  • 52 Week High
  • IMMP $3.34
  • VBF $16.27
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 39.93
  • VBF 43.86
  • Support Level
  • IMMP $1.44
  • VBF $14.78
  • Resistance Level
  • IMMP $1.56
  • VBF $15.08
  • Average True Range (ATR)
  • IMMP 0.12
  • VBF 0.30
  • MACD
  • IMMP 0.00
  • VBF -0.01
  • Stochastic Oscillator
  • IMMP 41.63
  • VBF 51.14

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About VBF Invesco Bond Fund

Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.

Share on Social Networks: